DK1098649T3 - Fremgangsmåde til stabilisering af farmaceutiske sammensætninger med speciel anvendelse af antioxidant - Google Patents

Fremgangsmåde til stabilisering af farmaceutiske sammensætninger med speciel anvendelse af antioxidant

Info

Publication number
DK1098649T3
DK1098649T3 DK99920582T DK99920582T DK1098649T3 DK 1098649 T3 DK1098649 T3 DK 1098649T3 DK 99920582 T DK99920582 T DK 99920582T DK 99920582 T DK99920582 T DK 99920582T DK 1098649 T3 DK1098649 T3 DK 1098649T3
Authority
DK
Denmark
Prior art keywords
antioxidant
pharmaceutical compositions
special use
stabilizing pharmaceutical
stabilizing
Prior art date
Application number
DK99920582T
Other languages
Danish (da)
English (en)
Inventor
Gyoergy Lajos Kis
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK1098649T3 publication Critical patent/DK1098649T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
DK99920582T 1998-04-02 1999-03-31 Fremgangsmåde til stabilisering af farmaceutiske sammensætninger med speciel anvendelse af antioxidant DK1098649T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98106046 1998-04-02

Publications (1)

Publication Number Publication Date
DK1098649T3 true DK1098649T3 (da) 2004-10-04

Family

ID=8231706

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99920582T DK1098649T3 (da) 1998-04-02 1999-03-31 Fremgangsmåde til stabilisering af farmaceutiske sammensætninger med speciel anvendelse af antioxidant

Country Status (21)

Country Link
US (2) US6576649B1 (fr)
EP (1) EP1098649B1 (fr)
JP (1) JP2002510627A (fr)
KR (1) KR100617430B1 (fr)
CN (1) CN1138542C (fr)
AT (1) ATE269079T1 (fr)
AU (1) AU756000B2 (fr)
BR (1) BR9909329A (fr)
CA (1) CA2326137C (fr)
CZ (1) CZ301851B6 (fr)
DE (1) DE69918122T2 (fr)
DK (1) DK1098649T3 (fr)
ES (1) ES2224651T3 (fr)
HU (1) HU226588B1 (fr)
ID (1) ID26033A (fr)
IL (2) IL138476A0 (fr)
NO (1) NO332004B1 (fr)
NZ (1) NZ507026A (fr)
PL (1) PL194914B1 (fr)
WO (1) WO1999051230A1 (fr)
ZA (1) ZA200005098B (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0938896A1 (fr) * 1998-01-15 1999-09-01 Novartis AG Compositions pharmaceutiques autoclavables contenant des agents de chelation
US6235781B1 (en) 1998-07-14 2001-05-22 Alcon Laboratories, Inc. Prostaglandin product
BR0016550A (pt) * 1999-12-21 2002-09-17 Dsm Nv Preservação da atividade de um fungicida em uma solução aquosa.
US6395756B2 (en) * 1999-12-23 2002-05-28 Novartis Ag Use of ophthalmic agent
KR100355892B1 (ko) * 2000-01-06 2002-10-12 주식회사 코리아나화장품 레티놀과 테트라디부틸 펜타에리스리틸히드록시히드로신나메이트를 함유하는 화장료 조성물
JP4822609B2 (ja) * 2000-05-22 2011-11-24 クラレメディカル株式会社 抗菌性組成物
WO2001090251A1 (fr) * 2000-05-22 2001-11-29 Kuraray Co., Ltd. Composition antimicrobienne
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
DE10041479A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
ES2396598T3 (es) * 2000-08-25 2013-02-22 Senju Pharmaceutical Co., Ltd. Preparaciones en forma de suspensiones acuosas
US20030027793A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal treatment of parkinson's disease
US20030026830A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
WO2002100436A2 (fr) * 2001-06-08 2002-12-19 Novartis Ag Compositions pharmaceutiques
US7479507B2 (en) * 2003-01-14 2009-01-20 Adam Heller Anti-inflammatory substituted phenols and elastomeric compositions for oral delivery of drugs
US6933289B2 (en) * 2003-07-01 2005-08-23 Allergan, Inc. Inhibition of irritating side effects associated with use of a topical ophthalmic medication
US20050220742A1 (en) * 2004-03-31 2005-10-06 Breen Ed V Compositions and methods for maintaining eyelid hygiene
US6969706B1 (en) * 2004-05-12 2005-11-29 Allergan, Inc. Preserved pharmaceutical compositions comprising cyclodextrins
CN1737047B (zh) * 2004-08-19 2010-05-05 住友化学株式会社 含填充材料的聚烯烃树脂组合物及其成形品
US20060089384A1 (en) * 2004-10-25 2006-04-27 Minno George E Ophthalmic compositions and methods of using the same
US20070208058A1 (en) * 2004-10-25 2007-09-06 Bryant Roy W Stable Pharmaceutical Compositions and Methods of Making and Using Same
EP1845983B1 (fr) * 2004-10-25 2010-04-07 Bausch & Lomb Incorporated Compositions ophtalmiques et methodes d'utilisation de ces compositions
US20070077302A1 (en) * 2005-09-30 2007-04-05 Azaam Alli Methods for stabilizing ophthalmic compositions
BRPI0709549A2 (pt) * 2006-03-17 2011-07-19 Johnson & Johnson Vision Care métodos para estabilizar composições instáveis oxidativamente
JP2009543736A (ja) * 2006-07-10 2009-12-10 ジョンソン・アンド・ジョンソン・ビジョン・ケア・インコーポレイテッド 医薬品を含有する眼用レンズのためのパッケージ
ES2624960T3 (es) * 2006-09-29 2017-07-18 Johnson & Johnson Vision Care, Inc. Método de fabricación de dispositivos oftálmicos usados en el tratamiento de alergias oculares
US20090005362A1 (en) * 2007-06-26 2009-01-01 Vo Toan P Compositions Comprising Antihistamines or Mast Cell Stabilizers, and Methods of Making and Using Same
US8986728B2 (en) * 2008-05-30 2015-03-24 Abbott Cardiovascular Systems Inc. Soluble implantable device comprising polyelectrolyte with hydrophobic counterions
US8300252B2 (en) * 2008-06-18 2012-10-30 Livescribe, Inc. Managing objects with varying and repeated printed positioning information
CN102076340B (zh) * 2008-06-27 2013-01-23 祐德药品工业株式会社 含芬太尼或其盐的经皮吸收型贴剂
KR20100023538A (ko) * 2008-08-22 2010-03-04 삼성전자주식회사 고상 시약의 제조방법 및 고상 시약을 수용하는 미세유동장치
WO2010047681A1 (fr) * 2008-10-24 2010-04-29 Bridge Pharma, Inc. Traitement de xérophthalmie à l'aide de norkétotifène
WO2010059894A1 (fr) * 2008-11-21 2010-05-27 Bridge Pharma, Inc. Formations oculaires de norkétotifène
KR101013102B1 (ko) * 2008-12-08 2011-02-14 주식회사 케이에스비 토너 카트리지의 블레이드 용접 장치
JP5675183B2 (ja) * 2009-06-16 2015-02-25 ロート製薬株式会社 水性組成物
FR2961694B1 (fr) * 2010-06-29 2013-01-25 Thea Lab Systeme de delivrance polymerique d'une solution non visqueuse a base de prostaglandine sans conservateur
US20180325854A1 (en) * 2015-11-06 2018-11-15 Accuitis Pharmaceuticals, Inc. Use of proteasome inhibitors to treat ocular disorders
CN114262476B (zh) * 2021-12-30 2023-09-05 沈阳兴齐眼药股份有限公司 提高妥布霉素滴眼液稳定性的包装容器
CN114262477B (zh) * 2021-12-30 2023-09-19 沈阳兴齐眼药股份有限公司 抑制妥布霉素滴眼液变色的包装容器及其制备方法
CN114441691B (zh) * 2022-04-12 2022-08-23 广州国标检验检测有限公司 一种眼用制剂容器中塑料添加剂的检测方法
US20240041869A1 (en) 2022-08-04 2024-02-08 Bausch + Lomb Ireland Limited Ophthalmic composition comprising an anti-allergen and a redness reduction agent
WO2024028816A1 (fr) 2022-08-04 2024-02-08 Bausch + Lomb Ireland Limited Composition ophtalmique comprenant de la pilocarpine et un agent de réduction de la rougeur

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2231377B1 (fr) * 1973-05-29 1977-11-04 Barnes Hind Pharm Inc
US3966905A (en) * 1973-05-29 1976-06-29 Barnes-Hind Pharmaceuticals, Inc. Stabilized catechol amine solutions
US4959208A (en) * 1987-10-19 1990-09-25 Ppg Industries, Inc. Active agent delivery device
JP3666884B2 (ja) * 1992-05-21 2005-06-29 日本ゼオン株式会社 医療用器材
JP3098895B2 (ja) * 1993-06-28 2000-10-16 三菱化学株式会社 液体用容器
JP3021312B2 (ja) * 1994-03-15 2000-03-15 千寿製薬株式会社 プラノプロフェンの安定化方法および安定なプラノプロフェン水性液剤
JP3055753B2 (ja) * 1994-07-05 2000-06-26 昭和薬品化工株式会社 フマル酸ケトチフェン含有点眼液
JP3693696B2 (ja) * 1994-12-15 2005-09-07 久光製薬株式会社 ケトチフェン含有経皮投与製剤
ES2144264T3 (es) * 1995-08-29 2000-06-01 Exxon Chemical Patents Inc Polipropileno tolerante a la radiacion y sus articulos utiles.
KR100228514B1 (ko) * 1996-09-05 1999-11-01 한승수 비스테로이드성 소염진통제를 활성성분으로 하는 경피흡수제제의 제조방법

Also Published As

Publication number Publication date
JP2002510627A (ja) 2002-04-09
ID26033A (id) 2000-11-16
KR100617430B1 (ko) 2006-08-31
IL138476A (en) 2006-04-10
US6576649B1 (en) 2003-06-10
HUP0101582A3 (en) 2002-10-28
ATE269079T1 (de) 2004-07-15
CZ20003579A3 (cs) 2001-01-17
CA2326137C (fr) 2009-06-02
AU3811999A (en) 1999-10-25
EP1098649B1 (fr) 2004-06-16
KR20010042361A (ko) 2001-05-25
NZ507026A (en) 2003-09-26
EP1098649A1 (fr) 2001-05-16
HU226588B1 (en) 2009-04-28
NO20004872L (no) 2000-11-09
ZA200005098B (en) 2001-05-21
CN1295474A (zh) 2001-05-16
PL343156A1 (en) 2001-07-30
AU756000B2 (en) 2003-01-02
DE69918122D1 (de) 2004-07-22
NO332004B1 (no) 2012-05-21
CZ301851B6 (cs) 2010-07-07
ES2224651T3 (es) 2005-03-01
US6455547B1 (en) 2002-09-24
PL194914B1 (pl) 2007-07-31
DE69918122T2 (de) 2005-06-16
US20020103196A1 (en) 2002-08-01
NO20004872D0 (no) 2000-09-28
IL138476A0 (en) 2001-10-31
CA2326137A1 (fr) 1999-10-14
WO1999051230A1 (fr) 1999-10-14
BR9909329A (pt) 2000-12-12
CN1138542C (zh) 2004-02-18
HUP0101582A2 (hu) 2002-03-28

Similar Documents

Publication Publication Date Title
DK1098649T3 (da) Fremgangsmåde til stabilisering af farmaceutiske sammensætninger med speciel anvendelse af antioxidant
DE69737592D1 (de) Mittel gegen juckreiz
DK0657458T3 (da) Inhibitorer af proteinkinase-C
EA199900373A2 (ru) Фармацевтические композиции
BR0215405A (pt) Composições e processos de uso de collajolie
DK1299348T3 (da) Forbindelser og sammensætninger til levering af aktive midler
NO20034056D0 (no) Proliferative sykdommer
DK1384478T3 (da) Antibiotiske sammensætninger indeholdende moxifloxacin til behandling af øjet
DK0695758T3 (da) Pentapeptidamider og -estere til inhibering af human cancer
BR0116452A (pt) Composto, composição farmacêutica, uso de um composto
DE69725825D1 (de) 5-HT1F-Agonisten
DE60007095D1 (de) Calanolide zur hemmung von btk
ATE231872T1 (de) Thiazolopyrimidinderivate
DK1056454T3 (da) Anvendelse af makrolidforbindelser til behandling af glaukom
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
DK0450991T3 (da) Anvendelse af phospholipider til behandling af luftvejsobstruktionssygdomme
TW200505443A (en) Combination of SCR kinase inhibitors and chemotherapeutic agents for the treatment of proliferative diseases
DK0956859T3 (da) Antioxiderende sammensætning til opfangning af frie radikaler, farmaceutisk præparat som omfatter denne samt fremgangsmåde til fremstilling heraf
TW200509896A (en) Analeptic and drug combinations
DE60112742D1 (de) Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit
EA200000520A1 (ru) 2-АРИЛ-3-АРОИЛБЕНЗО[b]ТИОФЕНЫ, ПОЛЕЗНЫЕ ДЛЯ ЛЕЧЕНИЯ СИНДРОМА ЭСТРОГЕННОЙ НЕДОСТАТОЧНОСТИ
DK0986387T3 (da) Farnesyl transferase inhibitorer i kombination med HMG CoA reduktase inhibitorer til behandling af cancer
MY127474A (en) Naphthyl compounds, intermediates, compositions, and methods of use
WO2004050613A3 (fr) Derives de 3-propenamide substitue en 2 et procedes d'utilisation de ces derives
SE0302361D0 (sv) Inhibering av upptagning av monoamin